基因治疗在心力衰竭中的研究进展

宇航 张, 明昊 王, 媛 陈, 虹 王

摘要


心力衰竭是一种复杂的临床综合征，发病率高，预后较差，是各种心脏疾病的严重阶段。其治愈率低，机制复杂，已有研究表明心力衰竭的发病机制与基因相关，如肾素 - 血管紧张素 - 醛固酮系统、交感 - 肾上腺髓质系统涉及到的基因。其他相关基因研究一直是近年来该领域的研究热点。论文对基因治疗在心力衰竭中的机制与应用予以综述，从而为心力衰竭治疗提供新的思路。

关键词


心力衰竭；基因治疗；临床试验

全文:

PDF

参考


Moran A E, Forouzanfar M H, Roth G A, et al. The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study [J]. Circulation, 2014, 129(14): 1493-1501.

Go A S, Mozaffarian D, Roger V L, et al. Executive summary: heart disease and stroke statistics-2014 update: a report from the American Heart Association [J]. Circulation, 2014, 129(3): 399-410.

Donato R. Intracellular and extracellular roles of S100 proteins [J]. Microscopy research and technique, 2003, 60(6): 540-551.

Völkers M, Loughrey C M, Macquaide N, et al. S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes [J]. Cell calcium, 2007, 41(2): 135-143.

Most P, Pleger S T, Völkers M, et al. Cardiac adenoviral S100A1 gene delivery rescues failing myocardium [J]. The Journal of clinical investigation, 2004, 114(11): 1550-1630.

Pleger S T, Shan C, Ksienzyk J, et al. Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model [J]. Science translational medicine, 2011, 3(92): 64r-92r.

Davis J, Maillet M, Miano J M, et al. Lost in transgenesis: a user’s guide for genetically manipulating the mouse in cardiac research [J]. Circulation research, 2012, 111(6): 761-777.

Yang M, Xiao Z, Chen Z, et al. S100A1 is Involved in Myocardial Injury Induced by Exhaustive Exercise [J]. International journal of sports medicine, 2022, 43(5): 444-540.

Stirrat C G, Venkatasubramanian S, Pawade T, et al. Cardiovascular effects of urocortin 2 and urocortin 3 in patients with chronic heart failure [J]. British journal of clinical pharmacology, 2016, 82(4): 974-982.

Venkatasubramanian S, Newby D E, Lang N N. Urocortins in heart failure [J]. Biochemical pharmacology, 2010, 80(3): 289-296.

Chan W Y, Frampton C M, Crozier I G, et al. Urocortin-2 infusion

Myers V D, Mcclung J M, Wang J, et al. The Multifunctional Protein BAG3: A Novel Therapeutic Target in Cardiovascular Disease [J]. JACC Basic to translational science, 2018, 3(1): 122-131.

Giamouridis D, Gao M H, Lai N C, et al. Effects of Urocortin 2 Versus Urocortin 3 Gene Transfer on Left Ventricular Function and Glucose Disposal [J]. JACC Basic to translational science, 2018, 3(2): 249-264.

SU F, Myers V D, Knezevic T, et al. Bcl-2-associated athanogene 3 protects the heart from ischemia/reperfusion injury [J]. JCI insight, 2016, 1(19): e90931.

Taheir F G, Knezevic T, Gupta M K, et al. Evidence for the Role of BAG3 in Mitochondrial Quality Control in Cardiomyocytes [J]. Journal of cellular physiology, 2017, 232(4): 797-805.

Fang X, Bogomolovas J, WU T, et al. Loss-of-function mutations in co-chaperone BAG3 destabilize small HSPs and cause cardiomyopathy [J]. The Journal of clinical investigation, 2017, 127(8): 3189-3200.

Toro R, Pérez-serra A, Campuzano O, et al. Familial Dilated Cardiomyopathy Caused by a Novel Frameshift in the BAG3 Gene

Myers V D, Gerhard G S, Mcnamara D M, et al. Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals [J]. JAMA cardiology, 2018, 3(10): 929-938.

Domínguez F, Cuenca S, BiliŃska Z, et al. Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations [J]. Journal of the American College of Cardiology, 2018, 72(20): 2471-2481.

Knezevic T, Myers V D, SU F, et al. Adeno-associated Virus Serotype 9 - Driven Expression of BAG3 Improves Left Ventricular Function in Murine Hearts with Left Ventricular Dysfunction Secondary to a Myocardial Infarction [J]. JACC Basic to translational science, 2016, 1(7): 647-656.

Zima A V, Bovo E, Mazurek S R, et al. Ca handling during excitation-contraction coupling in heart failure [J]. Pflugers Archiv: European journal of physiology, 2014, 466(6): 1129-1137.

Meyer M, Schillinger W, Pieske B, et al. Alterations of sarco plasmic reticulum proteins in failing human dilated cardiomyopathy [J]. Circulation, 1995, 92(4): 778-784.

Kawase Y, LY H Q, Prunier F, et al. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure [J]. Journal of the American College of Cardiology, 2008, 51(11): 1112-1119.




DOI: https://doi.org/10.12346/pmr.v4i6.7956

Refbacks

  • 当前没有refback。